These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 1553114)
1. A comparison of two pancreatin microsphere preparations in cystic fibrosis. Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages. Ansaldi-Balocco N; Santini B; Sarchi C J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. Trapnell BC; Maguiness K; Graff GR; Boyd D; Beckmann K; Caras S J Cyst Fibros; 2009 Dec; 8(6):370-7. PubMed ID: 19815466 [TBL] [Abstract][Full Text] [Related]
6. Two enteric coated microspheres in cystic fibrosis. Williams J; MacDonald A; Weller PH; Fields J; Pandov H Arch Dis Child; 1990 Jun; 65(6):594-7. PubMed ID: 2198848 [TBL] [Abstract][Full Text] [Related]
7. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis]. Zsíros J; Sólyom E Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773 [No Abstract] [Full Text] [Related]
8. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis. Chazalette JP; Dain MP; Castaigne JP J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S46-8. PubMed ID: 3042939 [TBL] [Abstract][Full Text] [Related]
9. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients. Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449 [TBL] [Abstract][Full Text] [Related]
10. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Safdi M; Bekal PK; Martin S; Saeed ZA; Burton F; Toskes PP Pancreas; 2006 Aug; 33(2):156-62. PubMed ID: 16868481 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415 [TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro studies of microsphere pancreatic supplements. Littlewood JM; Kelleher J; Walters MP; Johnson AW J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072 [TBL] [Abstract][Full Text] [Related]
13. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)]. Gottschalk B; Wiesemann HG; Stephan U Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230 [TBL] [Abstract][Full Text] [Related]
15. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic enzyme replacement therapy for young cystic fibrosis patients. Munck A; Duhamel JF; Lamireau T; Le Luyer B; Le Tallec C; Bellon G; Roussey M; Foucaud P; Giniès JL; Houzel A; Marguet C; Guillot M; David V; Kapel N; Dyard F; Henniges F J Cyst Fibros; 2009 Jan; 8(1):14-8. PubMed ID: 18718819 [TBL] [Abstract][Full Text] [Related]
18. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. Santini B; Antonelli M; Battistini A; Bertasi S; Collura M; Esposito I; Di Febbraro L; Ferrari R; Ferrero L; Iapichino L; Lucidi V; Manca A; Pisconti CL; Pisi G; Raia V; Romano L; Rosati P; Grazioli I; Melzi G Dig Liver Dis; 2000; 32(5):406-11. PubMed ID: 11030186 [TBL] [Abstract][Full Text] [Related]
20. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis. Warwick WJ; Budd JR Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]